M. Iyikesici

Long-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer

M. Iyikesici, 2019, Complementary Medicine Research.

Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer

M. Iyikesici, 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer

C. Chinopoulos, T. Seyfried, J. Spinosa, 2020, Frontiers in Nutrition.

Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer

T. Seyfried, Miriam Kalamian, M. Iyikesici, 2017, Cureus.

Long-Term Outcomes of the Treatment of Unresectable (Stage III - IV)Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study

E. Eyuboğlu, T. Ipek, E. Turkmen, 2016 .

Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.

G. Basaran, D. Cabuk, M. Teomete, 2014, International journal of clinical and experimental medicine.

Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer

M. Iyikesici, 2020, Nigerian journal of clinical practice.

Preliminary results of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in stage II-IV rectal cancer

M. Iyikesici, 2020 .

Metabolically Supported Chemotherapy for Managing End-Stage Breast Cancer: A Complete and Durable Response

T. Seyfried, Miriam Kalamian, M. Iyikesici, 2021, Cureus.

Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival

G. Basaran, Ç. Çelikel, D. Cabuk, 2007, Oncology.